PMID- 36868465 OWN - NLM STAT- MEDLINE DCOM- 20230609 LR - 20230621 IS - 1525-2191 (Electronic) IS - 0002-9440 (Linking) VI - 193 IP - 6 DP - 2023 Jun TI - Vitamin D and Microbiome: Molecular Interaction in Inflammatory Bowel Disease Pathogenesis. PG - 656-668 LID - S0002-9440(23)00055-X [pii] LID - 10.1016/j.ajpath.2023.02.004 [doi] AB - Studies of systemic autoimmune diseases point to characteristic microbial patterns in various diseases, including inflammatory bowel disease (IBD). Autoimmune diseases, and IBD in particular, show a predisposition to vitamin D deficiency, leading to alterations in the microbiome and disruption of intestinal epithelial barrier integrity. This review examines the role of the gut microbiome in IBD and discusses how vitamin D-vitamin D receptor (VDR)-associated molecular signaling pathways contribute to the development and progression of IBD through their effects on gut barrier function, the microbial community, and immune system function. The present data demonstrate that vitamin D promotes the proper function of the innate immune system by acting as an immunomodulator, exerting anti-inflammatory effects, and critically contributing to the maintenance of gut barrier integrity and modulation of the gut microbiota, mechanisms that may influence the IBD development and progression. VDR regulates the biological effects of vitamin D and is related to environmental, genetic, immunologic, and microbial aspects of IBD. Vitamin D influences the distribution of the fecal microbiota, with high vitamin D levels associated with increased levels of beneficial bacterial species and lower levels of pathogenic bacteria. Understanding the cellular functions of vitamin D-VDR signaling in intestinal epithelial cells may pave the way for the development of new treatment strategies for the therapeutic armamentarium of IBD in the near future. CI - Copyright (c) 2023 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. FAU - Aggeletopoulou, Ioanna AU - Aggeletopoulou I AD - Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, Patras, Greece; Laboratory of Immunohematology, Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, Patras, Greece. Electronic address: iaggel@upatras.gr. FAU - Marangos, Markos AU - Marangos M AD - Division of Infectious Diseases, Department of Internal Medicine, University Hospital of Patras, Patras, Greece. FAU - Assimakopoulos, Stelios F AU - Assimakopoulos SF AD - Division of Infectious Diseases, Department of Internal Medicine, University Hospital of Patras, Patras, Greece. FAU - Mouzaki, Athanasia AU - Mouzaki A AD - Laboratory of Immunohematology, Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, Patras, Greece. FAU - Thomopoulos, Konstantinos AU - Thomopoulos K AD - Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, Patras, Greece. FAU - Triantos, Christos AU - Triantos C AD - Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, Patras, Greece. LA - eng PT - Journal Article PT - Review DEP - 20230301 PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 1406-16-2 (Vitamin D) SB - IM MH - Humans MH - Vitamin D/metabolism MH - *Inflammatory Bowel Diseases MH - *Gastrointestinal Microbiome MH - Signal Transduction MH - *Autoimmune Diseases EDAT- 2023/03/04 06:00 MHDA- 2023/06/09 06:42 CRDT- 2023/03/03 19:30 PHST- 2022/11/21 00:00 [received] PHST- 2023/02/13 00:00 [revised] PHST- 2023/02/16 00:00 [accepted] PHST- 2023/06/09 06:42 [medline] PHST- 2023/03/04 06:00 [pubmed] PHST- 2023/03/03 19:30 [entrez] AID - S0002-9440(23)00055-X [pii] AID - 10.1016/j.ajpath.2023.02.004 [doi] PST - ppublish SO - Am J Pathol. 2023 Jun;193(6):656-668. doi: 10.1016/j.ajpath.2023.02.004. Epub 2023 Mar 1.